ProQR Therapeutics PRQR
NASDAQ PRQR
$1.40 +0.02 (+1.81%)
As of: Oct 21, 2026 · 1:13 PM EDT

ProQR Therapeutics (PRQR) Current Assets (2013 - 2026)

Updated

ProQR Therapeutics (PRQR) reported Current Assets of $141.38 million for the quarter ended Jun 30, 2026, up 0.5% from $140.68 million a year earlier and up 38.8% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Current Assets (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, ProQR Therapeutics posted Current Assets of $113.12 million, down 32.1% from the prior year.

  • Current Assets has a five-year compound annual growth rate of 4.4% (years ended Dec 2020 to Dec 2025).
  • By year, Current Assets came in at $166.51 million in the year ended Dec 31, 2024 (+27.2%), $130.87 million in the year ended Dec 31, 2023 (-19.6%), $162.79 million in the year ended Dec 31, 2022 (-28.2%) and $226.6 million in the year ended Dec 31, 2021 (+148.0%).
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Current Assets since the quarter ended Mar 31, 2025.
  • Year over year, Current Assets gained in five of the last eight quarters, with growth averaging 3.0%.
  • The high point for year-over-year Current Assets in five years was the quarter ended Dec 31, 2021 (growth of 129.6%); the low point was the quarter ended Sep 30, 2022 (a decline of 49.7%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $101.83 million (quarter ended Mar 31, 2026), $116.55 million (quarter ended Dec 31, 2025) and $130.15 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,133.02 Bn 1,101.60 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 616.49 Bn 535.01 Bn 17.26 Bn 59.77 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 33.67 Bn
4 Merck 366.78 Bn 321.16 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 297.96 Bn 261.95 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 27.97 Bn
7 Amgen 235.44 Bn 190.84 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 190.69 Bn 164.89 Bn 6.22 Bn 13.95 Bn
9 Pfizer 169.52 Bn 116.16 Bn 10.94 Bn 41.36 Bn
10 ProQR Therapeutics 147.99 Mn -312.66 Mn - 138.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 138.93 Mn
Mar 31, 2026 99.68 Mn
Dec 31, 2025 117.62 Mn
Sep 30, 2025 130.61 Mn
Jun 30, 2025 145.75 Mn
Mar 31, 2025 149.46 Mn
Dec 31, 2024 160.09 Mn
Sep 30, 2024 103.22 Mn
Jun 30, 2024 108.98 Mn
Mar 31, 2024 115.67 Mn
Dec 31, 2023 133.91 Mn
Sep 30, 2023 131.70 Mn
Jun 30, 2023 142.53 Mn
Mar 31, 2023 154.42 Mn
Dec 31, 2022 164.67 Mn
Sep 30, 2022 102.33 Mn
Jun 30, 2022 168.25 Mn
Mar 31, 2022 192.51 Mn
Dec 31, 2021 216.86 Mn
Sep 30, 2021 205.42 Mn
API Access

ProQR Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=PRQR&period=max&api_key=YOUR_API_KEY